semaglutide dr phillips Weight Loss San Diego & Encinitas, CA Phillips Pharma Launches First CGM

Novo Nordisk, the company that makes these weight-loss drugs, failed to warn about the increased risk of gastroparesis (also known as frozen stomach) for people taking GLP-1 RA treatments

Key Updates: Vision Loss Focus: While gastrointestinal claims are ongoing, cases involving NAION (blindness) are emerging as some of the strongest claims due to the sudden and permanent nature of the injury

Across the 12 mg group, 62.5% of participants lost at least a quarter of their body weight, 45.3% lost at least 30%, and a remarkable 27.2% crossed the 35% threshold

Dehydration reduces blood volume and oxygen delivery to your brain, amplifying any headache signals triggered by medication activation

Liver fat content was assessed with MRIPDFF and was expressed as the mean fat fraction across all nine user-defined regions of interest in the liver

The observation that differences in sex and age resulted in some subjects having better responsiveness to combined treatment with NSAIDs and GLP-1 M was also unexpected